Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Endocrinology
•
Pituitary Disorders
•
Primary Care
When and how do you taper off cabergoline therapy for treatment of microprolactinoma?
Answer from: at Community Practice
If patient does not desire fertility and microprolactinoma is stable or smaller, cabergoline can be tapered off.
Comments
at Northwestern University Endocrinology
The dose should be gradually tapered down to 0.5 m...
12127
Sign in or Register to read more
21564
Related Questions
How do you approach mild prolactin elevations (20-80) in women with galactorrhea on nipple stimulation but regular menses and no plans for pregnancy?
Do you recommend increased screening for hypercortisolism in older patients given recent evidence that older patients do not commonly display hallmark symptoms of Cushing's Disease?
For patients with metabolic syndrome, is it reasonable to wait for the effect of tirzepatide therapy on their lipid profile prior to starting statin therapy?
When do you consider using setmelanotide for treatment of hypothalamic obesity?
Do you recommend the use of Denosumab for osteoporosis management in patients receiving IVIG therapy?
How do you manage antipsychotic-induced prolactinemia?
How do you manage osteoporosis treatment following parathyroidectomy for primary hyperparathyroidism?
Do SSRIs affect the absorption of Levothyroxine therapy when taken concomitantly?
Is moderate-intensity statin plus ezetimibe just as effective as high-intensity statin monotherapy in preventing major cardiovascular events?
Is there any difference in the cardiovascular risk reduction profile of brand name vascepa versus generic icosapent ethyl for patients with hypertriglyceridemia?
The dose should be gradually tapered down to 0.5 m...